Introduction {#sec1_1}
============

Preeclampsia occurs in 2--8% of all pregnancies, and it is the leading cause of maternal and perinatal morbidity and mortality \[[@B1]\]. This multisystem disorder can occur after mid-gestation. It occurs in both nulliparous and multiparous women, and it is characterized by new-onset hypertension and proteinuria \[[@B2]\]. Hypertension is a key feature of preeclampsia which usually resolves within 3 months of delivery, but the associated risks are not always resolved \[[@B2]\].

The size of the enlarged left atrium (LA) is the most commonly used parameter for estimating the degree of atrial remodeling \[[@B3],[@B4],[@B5],[@B6]\]. In addition to LA volume and mechanical function, interatrial and intra-atrial conduction delay are also used. The atrial conduction time is important because it indicates LA electrical and structural remodeling \[[@B3]\]. P-wave dispersion (PWD) is an electrocardiographic (ECG) marker associated with a nonhomogeneous and discontinuous distribution of the sinus impulse \[[@B7]\]. In addition, PWD is accepted as a marker of prolonged interatrial and intra-atrial conduction times \[[@B8]\]. It has been reported that a prolonged PWD is an independent risk factor for the development of atrial fibrillation (AF) \[[@B7]\]. Although the atrial conduction time is indicative of the degree of atrial electrical remodeling, tissue Doppler echocardiography and 2 simple ECG markers -- maximum P-wave duration (Pmax) and PWD -- could provide information about prolongation of the atrial conduction time \[[@B7],[@B8],[@B9]\].

Prolonged interatrial and intra-atrial conduction times have been reported in chronic prehypertension \[[@B3]\] and systemic hypertension \[[@B4]\]; however, the effect of acute pressure overload on the atrial conduction time in women with preeclampsia remains unknown. Preeclampsia is a natural condition of acute pressure overload \[[@B2]\]. The aim of the present study was to determine the effect of short-term pressure overload, such as that which affects LA mechanical function, and atrial conduction time in women with preeclampsia.

Subjects and Methods {#sec1_2}
====================

Study Population {#sec2_1}
----------------

This study included 26 pregnant women with placental type preeclampsia (preeclampsia group) and 24 age-matched pregnant women without preeclampsia (control group). Preeclampsia was diagnosed using the criteria of the International Society for the Study of Hypertension in Pregnancy \[[@B10]\]. Therefore, in this study, preeclampsia was defined as: diastolic blood pressure ≥110 mm Hg on 1 occasion or diastolic blood pressure ≥90 mm Hg on 2 consecutive occasions \>4 h apart, in combination with proteinuria (300 mg total protein in 24-hour urine collection or, if this was not available, ≥2 proteinuria by dipstick analysis on 2 consecutive occasions ≥4 h apart) that developed after the 20th week of gestation in previously normotensive women.

The subjects were then classified as appropriate for gestational age (AGA), small for gestational age (SGA), or large for gestational age (LGA) based on their weight for gestational age. SGA was defined as a weight below the 10th percentile for gestational age, AGA was defined as a weight between the 10th and the 90th percentiles, and LGA was defined as a weight above the 90th percentile for gestational age.

Each participant provided written informed consent, and the study protocol was approved by the Institutional Ethics Committee. Exclusion criteria were: preeclampsia superimposed on chronic hypertension, a history of preeclampsia, significant valvular heart disease, atrial flutter or fibrillation, frequent ventricular preexcitation and atrioventricular conduction abnormality, renal failure, heart failure, pericarditis, collagen vascular disease, thyroid dysfunction, hypercholesterolemia, electrolyte imbalance, pulmonary disease, a technically insufficient echocardiographic image, and an ECG in which the start or end of the P-wave could not be clearly discerned.

PWD Measurement via a 12-Lead ECG {#sec2_2}
---------------------------------

Following 10 min of rest, each participant underwent a 12-lead ECG in the supine position, conducted at a rate of 50 mm·s^−1^ with an amplitude of 20 mm·mV^−1^. ECG were manually measured using a magnifying glass by 2 cardiologists who were blinded to the clinical status of the patients. The starting point of the first positive wave moving in an upward direction or the first negative wave moving in a downward direction that could be observed from the isoelectric line was considered the origin of the P-wave. The turning point of the wave toward the isoelectric line was considered the end of the P-wave. PWD was calculated based on measurement of the longest (Pmax) and shortest (Pmin) P-waves in any lead of the 12-lead ECG \[[@B11]\] (PWD = Pmax -- Pmin). The intra- and interobserver coefficients of variation (SD of the differences between 2 observations were divided by the mean value and expressed as percentages) were 4.5 and 3.2% for PWD.

Standard Echocardiography {#sec2_3}
-------------------------

Echocardiographic examination of the patients in both groups was performed in the left decubitus position using a GE Vingmed Vivid 5 echocardiography device (GE Vingmed Ultrasound, Horten, Norway). All measurements were performed by 2 cardiologists (S.İ. and G.N.) experienced in echocardiography who were blinded to the clinical status of the patients. During the echocardiographic evaluation, a 1-lead echocardiography was recorded. Parasternal long-axis, short-axis, and apical 4-chamber and 2-chamber images were obtained and evaluated using M-mode, 2-D, continuous wave Doppler, pulse wave Doppler, and tissue Doppler methods according to American Echocardiography Society criteria. The cardiac output was calculated using measurements obtained from the left ventricular (LV) outflow tract diameter (cross-sectional area), the Doppler-derived velocity time integral of the LV outflow tract, and the heart rate. The LV outflow tract diameter measurement was taken using the parasternal long-axis view, and the LV outflow tract velocity time integral was obtained from the apical 4-chamber view \[[@B12]\]. Values were measured for 3 separate beats and then averaged for all parameters.

Assessment of LA Mechanical Function {#sec2_4}
------------------------------------

The LA volume was determined based on apical 4-chamber views \[[@B13]\], and the LA maximum volume (Vmax) at the end-systolic phase, the LA minimum volume (Vmin) at the end-diastolic phase, and the LA volume before atrial systole (Vp) (origin of the P-wave via ECG) were measured and calculated, indexed to the body surface area. Parameters of LA function were calculated as follows:

LA passive emptying volume = Vmax − Vp

LA passive emptying fraction = \[(Vmax − Vp)/Vmax\] **∙** 100%

LA active emptying volume = Vp − Vmin

LA active emptying fraction = \[(Vp − Vmin)/Vp\] **∙** 100%

LA total emptying volume = Vmax − Vmin

LA ejection fraction = \[(Vmax − Vmin)/Vmax\] **∙** 100% \[[@B14]\].

Interatrial and Intra-Atrial Electromechanical Delay {#sec2_5}
----------------------------------------------------

All electromechanical delay (EMD) times used to measure interatrial and intra-atrial EMD were determined using tissue Doppler imaging and concurrent ECG rhythm traces. Atrial systole was considered as the A-wave (A) that was the second negative deviation at diastole in the tissue Doppler trace. The time from the onset of the P-wave on the surface ECG and the delayed diastolic wave (A) on tissue Doppler was considered PA, whereas measurements were obtained from the lateral mitral annulus (PA lateral), the septal annulus (PA septal), and the LV tricuspid annulus (PA tricuspid) on an apical 4-chamber image in a manner in which the 5 cardiac cycles were averaged \[[@B15]\]. Interatrial and intra-atrial EMD were calculated as follows \[[@B16]\]: theinteratrial EMD is the difference in time between PA lateral and PA tricuspid, while the intra-atrial EMD is the difference in time between PA septal and PA tricuspid.

All measurements were performed by 2 experienced investigators (S.İ. and G.N.) blinded to the clinical status of the patients. The reproducibility of electromechanical parameters was assessed based on coefficients of variation (SD of the differences between the repeated measurements divided by the mean value and then expressed as a percentage) between measurements. Intraobserver variability was calculated based on 50 randomly selected patients (26 from the preeclampsia group and 24 from the control group) by repeating the measurements under identical basal conditions. Intraobserver variability was 3.2% for PA lateral, 3.3% for PA septal, and 3.1% for PA tricuspid. The interobserver variability was 4.7% for PA lateral, 4.6% for PA septal, and 4.7% for PA tricuspid.

Statistical Analysis {#sec2_6}
--------------------

All data were analyzed using SPSS v.15.0 for Windows (SPSS, Inc., Chicago, Ill., USA). Categorical variables are presented as frequencies and percentages, and continuous variables are expressed as means ± SD. The normality of the distribution of continuous variables was tested using the Kolmogorov-Smirnov test. Differences in continuous variables between groups were examined using the nonparametric Mann-Whitney U test. Correlation analysis was performed using Spearman\'s coefficient of correlation. Categorical values were compared using a χ^2^ test. p \< 0.05 was considered statistically significant.

Results {#sec1_3}
=======

Clinical and laboratory findings are shown in table [1](#T1){ref-type="table"}. There were no significant differences in age, BMI, heart rate, lipid parameters, creatinine, glucose, white blood cell counts, hemoglobin, or thrombocyte values between the groups (p \> 0.05). Systolic and diastolic blood pressures were significantly higher and gestational age was significantly lower in the preeclampsia group. Based on conventional echocardiographic measurements, there were no significant differences in ventricular septal thickness, posterior wall thickness, LV end-diastolic dimensions, LV end-systolic dimensions, LV ejection fraction, LA, RV dimensions, or systolic pulmonary arterial pressure parameters, or such diastolic parameters as deceleration time, isovolumetric relaxation time, early diastolic flow (E), atrial contraction signal (A) values, and the E/A ratio between groups (p \> 0.05) (table [2](#T2){ref-type="table"}).

The LA volume indices are shown in table [3](#T3){ref-type="table"}. There were no significant differences in LA diameter, LAVmax, LAVmin, LAVp, LA passive emptying volume, LA passive emptying fraction, LA active emptying volume, LA active emptying fraction, conduit volume, LA total emptying volume, or LA total emptying fraction between the preeclampsia and control groups (p \> 0.05). Atrial electromechanical coupling parameters at different sites measured via tissue Doppler imaging are shown in table [4](#T4){ref-type="table"}. PA lateral and PA septal durations were significantly longer in the preeclampsia group than in the control group \[74.6 ± 8.1 vs. 62.3.4 ± 5.3 ms (p \< 0.001) and 59.7 ± 5.3 vs. 56.2 ± 4.9 ms (p = 0.005), respectively\]. There was no significant difference in PA tricuspid duration between the preeclampsia and control groups (49.2 ± 4.6 vs. 48.9 ± 4.8 ms; p = 0.836). Increased interatrial (PA lateral -- PA tricuspid) and intra-atrial (PA septal -- PA tricuspid) EMD were observed in the preeclampsia group \[25.4 ± 4.6 vs. 13.2 ± 3.9 ms and 10.5 ± 1.9 vs. 7.1 ± 1.2 ms (p \< 0.001), respectively\].

P-wave measurements are presented in table [4](#T4){ref-type="table"}. Pmax did not differ significantly between the groups (104.5 ± 11.2 vs. 97.5 ± 10.2 ms; p = 0.051). Pmin and PWD were significantly higher in the preeclampsia group than in the control group \[61.3 ± 7.4 vs. 57.1 ± 7.9 ms (p = 0.011) and 43.1 ± 9.1 vs. 37.6 ± 7.9 ms (p = 0.008), respectively\]. There was a significant correlation between PWD and interatrial EMD and intra-atrial EMD \[r = 0.46 (p \< 0.001) and r = 0.39 (p \< 0.001), respectively; fig. [1](#F1){ref-type="fig"}\].

Discussion {#sec1_4}
==========

In this study, the PWD time and the atrial EMD time were significantly prolonged in patients with preeclampsia compared to those without preeclampsia; there was no statistically significant difference in LA mechanical function between the 2 groups, and PWD was correlated with the atrial electromechanical conduction interval.

AF is among the most important causes of stroke, and its incidence is increased in hypertensive patients due to the development of LV diastolic dysfunction in cases of arterial hypertension; fibrosis occurs in the LA and LV \[[@B17]\]. Prolongation of intra-atrial and interatrial EMD and inhomogeneous propagation of sinus impulses are well-known electrophysiological characteristics of atria prone to fibrillation \[[@B5],[@B6],[@B9],[@B18],[@B19]\]. PWD is associated with inhomogeneous and interrupted conduction of sinus impulses, both intra-atrially and interatrially \[[@B19]\]. Our hypothesis is based on the fact that electrical and structural LA changes that occur in chronic arterial hypertension might also occur in cases of acute hypertension -- including preeclampsia -- and might play a role in altering the atrial EMD time. A prolonged atrial conduction time and increased PWD can occur due to many physiopathological mechanisms that develop on a chronic basis. However, this association is not clear in the case of acute hypertension, including preeclampsia. One such mechanism could be the fact that hypertension in preeclampsia may lead to enhanced atrial stretch, even in the acute phase. Even though it does not affect LA mechanical function like chronic atrial stretching does, it may influence electrical functions. Another possible mechanism might be increased sympathetic activation. Studies have reported prolongation of PWD and the conduction time with increased sympathetic activity \[[@B20]\]. Another mechanism might be increased angiotensin II due to activation of the renin-angiotensin system. Clinical and experimental studies have shown that angiotensin II could be directly involved in atrial electrical remodeling \[[@B21]\]. Another mechanism may be associated with the inflammatory process that occurs in early preeclampsia \[[@B22]\]. Therefore, the extended PWD and AEMG times observed in preeclampsia patients may result from the electrical remodeling caused by acute hypertension on the atrium through the above-mentioned mechanisms.

In the present study, there was no significant difference in LA mechanical function between the preeclampsia and control groups. Similarly, the nonstatistically significant difference in LA mechanical function between the preeclampsia and control groups confirmed the previous finding \[[@B23]\] that LA function is not affected by short-term pressure overload. A plausible explanation could be that LA function is influenced by long-term pressure overload \[[@B24]\], but not by short-term pressure overload, because of the fact that short-term hypertension does not affect LA mechanical function.

P-wave duration and PWD are the most important ECG markers used to assess the risk of atrial arrhythmia, and they have also been shown to be predictive of the development of AF \[[@B11]\]. Prolonged PWD is observed in many clinical conditions, including metabolic syndrome, obstructive sleep apnea, congestive heart failure, rheumatoid arthritis, and psoriasis, and this is associated with further AF development \[[@B7],[@B25],[@B26],[@B27]\]. Dilaveris et al. \[[@B28]\] reported that PWD is prolonged in hypertensive patients with a history of AF and that prolonged PWD might be a predictor of paroxysmal AF. Ermis et al. \[[@B29]\] observed that PWD was prolonged in dipper and nondipper hypertensive patients, compared to controls, and that PWD was significantly prolonged in nondippers. Emiroglu et al. \[[@B4]\] showed that patients with hypertension had prolonged PWD. The prolonged PWD observed in the present study is consistent with the aforementioned studies. Prolonged PWD probably arises from the effect of physiopathological mechanisms caused by arterial hypertension. Hence, a close association between PWD and sympathetic activity had been shown in earlier studies \[[@B20]\], but the literature does not include any studies on PWD in preeclampsia patients.

Interatrial and intra-atrial EMD and the nonhomogeneous spread of sinus stimulation are well-known electrophysiological characteristics of atria that are prone to AF. Atrial EMD can be measured using invasive and noninvasive methods. Tissue Doppler imaging, along with advanced echocardiographic techniques, is an alternative method \[[@B5],[@B6]\]. Unlike the LA volume, the atrial conduction time can indicate both structural and electrical remodeling in the atria. In the present study, atrial EMD was significantly prolonged in the preeclampsia group, and a correlation between PWD and both interatrial and intra-atrial conduction delay was observed. Similarly, previous studies have shown that atrial EMD is significantly prolonged in paroxysmal AF patients \[[@B5],[@B6]\]. Atrial EMD is prolonged in various groups of patients, including those with essential hypertension, prehypertension, and nondipper hypertension, and there is a correlation between PWD and interatrial EMD \[[@B3],[@B4],[@B29]\].

On the basis of the present findings, we speculate that prolonged intra-atrial and interatrial EMD might be an early form of subclinical cardiac involvement in preeclampsia patients who do not have any clinical evidence of cardiovascular disease. Hence, the risk of new and/or recurrent AF might be high in preeclampsia patients.

The major limitations of the present study were its cross-sectional design, the lack of patient follow-up, and the small study population. Because the patients were not followed up for arrhythmic events, it is not known whether PWD and prolonged atrial EMD were predictors of atrial arrhythmias. Another limitation was that our patient group had placental preeclampsia (cardiac changes may start in the first trimester in this type of preeclampsia) and the patients were not followed up during the first trimester. The other limitation was the use of a 12-lead ECG instead of a signal-averaged electrocardiogram to evaluate P-wave duration. Long-term follow-up and large-scale prospective studies are needed to more clearly determine the predictive value of prolonged intra-atrial and interatrial EMD in patients with preeclampsia.

Conclusion {#sec1_5}
==========

Prolonged intra-atrial and interatrial EMD and PWD were observed in preeclampsia patients compared to controls. These parameters, which are associated with an increased risk of AF, might be predictors of the risk of AF in preeclampsia patients. A more thorough and earlier assessment of preeclampsia patients in cardiac terms is important in order to avoid subclinical cardiac damage in these patients.
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###### 

Baseline clinical and laboratory characteristics

                                                       Preeclampsia group (n = 36)   Control group (n = 34)   p value
  ---------------------------------------------------- ----------------------------- ------------------------ ---------
  Age, years                                           30.1 ± 5.7                    29.3 ± 3.6               0.432
  Nulliparous, n (%)                                   26 (72)                       21 (61)                  0.863
  Multiparous, n (%)                                   10 (28)                       13 (39)                  0.755
  Gestational age, weeks                               35.9 ± 1.4                    38.1 ± 0.8               \<0.001
  Preeclampsia duration at cardiac assessment, weeks   9.7 ± 2.5                                              
  Mean birth weight, g                                 2,985 ± 224                   3,467 ± 435              \<0.001
  SGA, n (%)                                           16 (44.4)                     2 (5.9)                  \<0.001
  AGA, n (%)                                           18 (55.6)                     29 (85.3)                \<0.001
  LGA, n (%)                                           0                             3 (8.8)                  \<0.001
  BMI                                                  28.6 ± 5                      27.1 ± 3.9               0.090
  Smoking, n (%)                                       9 (25)                        8 (24)                   0.825
  Systolic blood pressure, mm Hg                       164.4 ± 4.8                   116.3 ± 14.3             \<0.001
  Diastolic blood pressure, mm Hg                      105.4 ± 4.2                   72.3 ± 13.1              \<0.001
  Heart rate, bpm                                      88.3 ± 10                     85.6 ± 10                0.258
  Creatinine, mg·dl^--1^                               0.82 ± 0.1                    0.78 ± 0.1               0.422
  Serum glucose, mg·dl^--1^                            86.2 ± 10.4                   87.7 ± 10.9              0.571
  Triglyceride, mg·dl^--1^                             157.2 ± 47.2                  148.4 ± 57.4             0.445
  Low-density lipoprotein cholesterol, mg·dl^--1^      125.0 ± 37                    134.2 ± 36.9             0.283
  High-density lipoprotein cholesterol, mg·dl^--1^     48.4 ± 9.3                    51.3 ± 9.8               0.436
  Total cholesterol, mg·dl^--1^                        202.6 ± 38.7                  212.4 ± 36.8             0.484
  Hemoglobin, g·dl^--1^                                12.2 ± 1.6                    12.4 ± 2.0               0.122
  White blood cell count, n·10^3^·mm^--3^              7.27 ± 1.56                   7.56 ± 1.87              0.382
  Platelets, n·10^3^·mm^--3^                           155.2 ± 51.8                  188.4 ± 58.5             0.286

###### 

Conventional echocardiographic parameters

                      Preeclampsia group (n = 36)   Control group (n = 34)   p value
  ------------------- ----------------------------- ------------------------ ---------
  IVS thickness, mm   9.5 ± 1.5                     8.9 ± 1.5                0.214
  PW thickness, mm    9.2 ± 1.2                     8.6 ± 1.5                0.355
  LVEDD, mm           46.2 ± 4.5                    45.8 ± 3.8               0.757
  LVESD, mm           29.4 ± 5.6                    29.9 ± 3.1               0.595
  LA dimension, mm    33.7 ± 3.5                    33.1 ± 4.6               0.386
  LVEF, %             64.3 ± 5.1                    63.7 ± 4.4               0.573
  RV dimension, mm    27.1 ± 2.5                    27.4 ± 2.6               0.844
  PAB(s), mm Hg       24.2 ± 5.3                    23.4 ± 5.5               0.856
  DT, ms              175.3 ± 26.9                  172.4 ± 27.2             0.388
  IVRT, ms            86.2 ± 13.2                   83.4 ± 14.5              0.258
  E, m·s^--1^         0.55 ± 0.19                   0.58 ± 0.19              0.563
  A, m·s^--1^         0.49 ± 0.14                   0.51 ± 0.11              0.422
  E/A ratio           1.1 ± 0.4                     1.1 ± 0.3                0.618
  CO, ml/min          5,790 ± 625                   7,986 ± 744              \<0.001

IVS = Ventricular septal thickness; PW = posterior wall thickness; LVEDD = left ventricular end-diastolic dimension; LVESD = left ventricular end-systolic dimension; LA = left atrium; LVEF = left ventricular ejection fraction; RV = right ventricular; PAB(s) = systolic pulmonary artery pressure; DT = deceleration time; IVRT = isovolumetric relaxation time; CO = cardiac output.

###### 

LA volume measurements and mechanical function

                       Preeclampsia group (n = 36)   Control group (n = 34)   p value
  -------------------- ----------------------------- ------------------------ ---------
  LA Vmax, ml·m^--2^   33.4 ± 6.7                    34.5 ± 6.8               0.343
  LA Vmin, ml·m^--2^   11.4 ± 3.1                    12.1 ± 3.4               0.446
  LA Vp, ml·m^--2^     22.4 ± 4.8                    21.8 ± 5.4               0.348
  LAEF, %              34.6 ± 6.8                    34.4 ± 7.1               0.458
  LATEV, ml·m^--2^     21.2 ± 4.8                    22.5 ± 5.1               0.389
  LAAEF, %             0.33 ± 0.11                   0.33 ± 0.13              0.959
  LAAEV, ml·m^--2^     8.8 ± 3.4                     8.3 ± 4.1                0.585
  LAPEF, %             0.29 ± 0.06                   0.30 ± 0.10              0.661
  LAPEV, ml·m^--2^     11.6 ± 3.7                    11.2 ± 4.4               0.669

LAEF = Left atrium ejection fraction; LATEV = left atrium total emptying volume; LAAEF = left atrium active emptying fraction; LAAEV = left atrium active emptying volume; LAPEF = left atrium passive emptying fraction; LAPEV = left atrium passive emptying volume.

###### 

Electrocardiographic and tissue Doppler echocardiographic findings

                     Preeclampsia group (n = 36)   Control group (n = 34)   p value
  ------------------ ----------------------------- ------------------------ ---------
  PA lateral, ms     74.6 ± 8.1                    62.3 ± 5.3               \<0.001
  PA septal, ms      59.7 ± 5.3                    56.2 ± 4.9               0.005
  PA tricuspid, ms   49.2 ± 4.6                    48.9 ± 4.8               0.836
  IA-EMD, ms         25.4 ± 4.6                    13.2 ± 3.9               \<0.001
  IRight-EMD, ms     10.5 ± 1.9                    7.1 ± 1.2                \<0.001
  Pmax, ms           104.5 ± 11.2                  97.5 ± 10.2              0.051
  Pmin, ms           61.3 ± 7.4                    57.1 ± 7.9               0.011
  PWD, ms            43.1 ± 9.1                    37.6 ± 7.9               0.008

PA = Time interval from the onset of the P-wave on the surface ECG to the beginning of the late diastolic wave (A wave); IA-EMD = interatrial electromechanical delay; IRight-EMD = intra-right electromechanical delay.
